IP Library Assignment 025911/0697
Patent Assignment
Reel/Frame 025911/0697

Assignment of Assignor's Interest

Recorded: 2011-03-07 Pages: 3
Assignor
Assignee
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
BINGER STRASSE 173, INGELHEIM, 55216, GERMANY
Covered Property (1)
Isoquinolinone Rho Kinase Inhibitors
Patent: 8,809,326 →
Application: 11/856,740 →
Publication: US 2008/0161297
Related Assignments (9)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 7, 2011
From: BOSANAC, TODD; GINN, JOHN DAVID; HICKEY, EUGENE RICHARD; KIRRANE, THOMAS MARTIN, JR.
To: BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.
Reel/Frame 025911/0396 →
Assignment of Assignor's Interest May 11, 2011
From: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
To: AERIE PHARMACEUTICALS, INC.
Reel/Frame 026261/0212 →
Assignment of Assignor's Interest Jan 13, 2012
From: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
To: AERIE PHARMACEUTICALS, INC.
Reel/Frame 027528/0974 →
Security Interest Sep 11, 2014
From: AERIE PHARMACEUTICALS, INC.
To: DEERFIELD MANAGEMENT COMPANY, L.P., AS AGENT; DEERFIELD PARTNERS, L.P.; DEERFIELD INTERNATIONAL MASTER FUND, L.P.; DEERFIELD PRIVATE DESIGN FUND III, L.P.
Reel/Frame 033726/0043 →
Security Interest Jul 23, 2018
From: AERIE PHARMACEUTICALS, INC.
To: DEERFIELD PRIVATE DESIGN FUND III, L.P.
Reel/Frame 046432/0307 →
Release of Security Interest Jul 23, 2018
From: DEERFIELD PARTNERS, L.P.; DEERFIELD PRIVATE DESIGN FUND III, L.P.; DEERFIELD SPECIAL SITUATIONS FUND, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P.
To: AERIE PHARMACEUTICALS, INC.
Reel/Frame 046431/0600 →
Release of Security Interest Jul 23, 2018
From: DEERFIELD PARTNERS, L.P.; DEERFIELD PRIVATE DESIGN FUND III, L.P.; DEERFIELD SPECIAL SITUATIONS FUND, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P.
To: AERIE DISTRIBUTION, INC.
Reel/Frame 046431/0500 →
Release of Security Interest Sep 5, 2019
From: DEERFIELD PRIVATE DESIGN FUND III, L.P.
To: AERIE PHARMACEUTICALS, INC.
Reel/Frame 050276/0807 →
Assignment of Assignor's Interest Jun 24, 2024
From: AERIE PHARMACEUTICALS, INC.
To: ALCON INC.
Reel/Frame 067822/0168 →